healthcare services group inc. - HCSG
HCSG
Close Chg Chg %
18.82 0.38 2.02%
Closed Market
19.20
+0.38 (2.02%)
Volume: 1.29M
Last Updated:
Apr 8, 2026, 4:00 PM EDT
Company Overview: healthcare services group inc. - HCSG
HCSG Key Data
| Open $19.44 | Day Range 19.10 - 19.73 |
| 52 Week Range 9.13 - 22.98 | Market Cap $1.32B |
| Shares Outstanding 70.27M | Public Float 69.49M |
| Beta 0.81 | Rev. Per Employee N/A |
| P/E Ratio 23.27 | EPS $0.83 |
| Yield 0.00% | Dividend $0.22 |
| EX-DIVIDEND DATE Nov 17, 2022 | SHORT INTEREST N/A |
| AVERAGE VOLUME 683.21K |
HCSG Performance
| 1 Week | 2.56% | ||
| 1 Month | -8.86% | ||
| 3 Months | -2.54% | ||
| 1 Year | 92.63% | ||
| 5 Years | -34.68% |
HCSG Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
6
Full Ratings ➔
About healthcare services group inc. - HCSG
Healthcare Services Group, Inc. engages in the provision of healthcare management, administrative, and operating services. It operates through the following segments: Environmental Services (EVS) and Dietary. The EVS segment involves housekeeping, laundry, linen, and other services. The Dietary segment includes food purchasing, meal preparation, development of menus, and the provision of dietician consulting professional services. The company was founded by Daniel P. McCartney on November 22, 1976 and is headquartered in Bensalem, PA.
HCSG At a Glance
Healthcare Services Group, Inc.
3220 Tillman Drive
Bensalem, Pennsylvania 19020
| Phone | 1-215-639-4274 | Revenue | 1.84B | |
| Industry | Miscellaneous Commercial Services | Net Income | 59.06M | |
| Sector | Commercial Services | 2025 Sales Growth | 7.081% | |
| Fiscal Year-end | 12 / 2026 | Employees | 36,000 | |
| View SEC Filings |
HCSG Valuation
| P/E Current | 23.235 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 23.643 |
| Price to Sales Ratio | 0.76 |
| Price to Book Ratio | 2.608 |
| Price to Cash Flow Ratio | 9.63 |
| Enterprise Value to EBITDA | 47.249 |
| Enterprise Value to Sales | 0.657 |
| Total Debt to Enterprise Value | 0.012 |
HCSG Efficiency
| Revenue/Employee | 51,032.583 |
| Income Per Employee | 1,640.528 |
| Receivables Turnover | 5.488 |
| Total Asset Turnover | 2.264 |
HCSG Liquidity
| Current Ratio | 3.383 |
| Quick Ratio | 3.285 |
| Cash Ratio | 1.197 |
HCSG Profitability
| Gross Margin | 15.67 |
| Operating Margin | 0.478 |
| Pretax Margin | 3.694 |
| Net Margin | 3.215 |
| Return on Assets | 7.277 |
| Return on Equity | 11.693 |
| Return on Total Capital | 11.244 |
| Return on Invested Capital | 11.492 |
HCSG Capital Structure
| Total Debt to Total Equity | 2.943 |
| Total Debt to Total Capital | 2.859 |
| Total Debt to Total Assets | 1.859 |
| Long-Term Debt to Equity | 1.893 |
| Long-Term Debt to Total Capital | 1.839 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Healthcare Services Group Inc. - HCSG
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 1.69B | 1.67B | 1.72B | 1.84B | |
Sales Growth
| +2.94% | -1.11% | +2.65% | +7.08% | |
Cost of Goods Sold (COGS) incl D&A
| 1.46B | 1.42B | 1.44B | 1.55B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 15.40M | 14.30M | 14.59M | 16.78M | |
Depreciation
| 10.50M | 10.50M | 11.88M | 13.08M | |
Amortization of Intangibles
| 4.90M | 3.80M | 2.70M | 3.70M | |
COGS Growth
| +4.26% | -3.03% | +1.51% | +7.48% | |
Gross Income
| 225.81M | 251.45M | 274.25M | 287.88M | |
Gross Income Growth
| -4.87% | +11.36% | +9.07% | +4.97% | |
Gross Profit Margin
| +13.36% | +15.04% | +15.98% | +15.67% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 181.49M | 189.09M | 238.06M | 279.11M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 181.49M | 189.09M | 238.06M | 279.11M | |
SGA Growth
| -4.61% | +4.19% | +25.90% | +17.24% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| (9.18M) | 13.28M | (8.24M) | (45.06M) | |
EBIT after Unusual Expense
| 53.50M | 49.07M | 44.43M | 53.84M | |
Non Operating Income/Expense
| (5.43M) | 11.84M | 14.95M | 15.61M | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 2.99M | 7.86M | 6.44M | 1.58M | |
Interest Expense Growth
| +115.67% | +163.01% | -18.05% | -75.46% | |
Gross Interest Expense
| 2.99M | 7.86M | 6.44M | 1.58M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 45.08M | 53.06M | 52.94M | 67.87M | |
Pretax Income Growth
| -27.08% | +17.69% | -0.22% | +28.19% | |
Pretax Margin
| +2.67% | +3.17% | +3.09% | +3.69% | |
Income Tax
| 10.45M | 14.67M | 13.47M | 8.81M | |
Income Tax - Current - Domestic
| 5.40M | 19.49M | 16.41M | (10.25M) | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| 5.05M | (4.82M) | (2.94M) | 19.06M | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 34.63M | 38.39M | 39.47M | 59.06M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 34.63M | 38.39M | 39.47M | 59.06M | |
Net Income Growth
| -24.49% | +10.85% | +2.83% | +49.63% | |
Net Margin Growth
| +2.05% | +2.30% | +2.30% | +3.21% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 34.63M | 38.39M | 39.47M | 59.06M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 34.63M | 38.39M | 39.47M | 59.06M | |
EPS (Basic)
| 0.4659 | 0.5167 | 0.5352 | 0.816 | |
EPS (Basic) Growth
| -24.00% | +10.90% | +3.58% | +52.47% | |
Basic Shares Outstanding
| 74.34M | 74.29M | 73.75M | 72.38M | |
EPS (Diluted)
| 0.4658 | 0.5164 | 0.5335 | 0.8087 | |
EPS (Diluted) Growth
| -23.86% | +10.86% | +3.31% | +51.58% | |
Diluted Shares Outstanding
| 74.35M | 74.34M | 73.99M | 73.03M | |
EBITDA
| 59.72M | 76.66M | 50.77M | 25.56M | |
EBITDA Growth
| -3.31% | +28.37% | -33.77% | -49.67% | |
EBITDA Margin
| +3.53% | +4.59% | +2.96% | +1.39% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 24.50 | |
| Number of Ratings | 6 | Current Quarters Estimate | 0.237 | |
| FY Report Date | 06 / 2026 | Current Year's Estimate | 0.964 | |
| Last Quarter’s Earnings | 0.215 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.10 | Next Fiscal Year Estimate | 1.098 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 6 | 6 | 6 | 6 |
| Mean Estimate | 0.24 | 0.25 | 0.96 | 1.10 |
| High Estimates | 0.25 | 0.27 | 1.04 | 1.21 |
| Low Estimate | 0.21 | 0.23 | 0.90 | 0.98 |
| Coefficient of Variance | 6.63 | 6.05 | 5.41 | 8.70 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 3 | 3 | 2 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 3 | 3 | 3 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Healthcare Services Group Inc. - HCSG
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Healthcare Services Group Inc. - HCSG
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 27, 2026 | Andrew M. Brophy SVP & Chief Accounting Officer | 15,735 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $21.75 per share | 342,236.25 |
| Feb 27, 2026 | Andrew W. Kush EVP & Chief Operating Officer | 8,830 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2026 | Andrew W. Kush EVP & Chief Operating Officer | 38,339 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $21.4 per share | 820,454.60 |
| Feb 27, 2026 | Andrew W. Kush EVP & Chief Operating Officer | 43,692 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2026 | Andrew W. Kush EVP & Chief Operating Officer | 31,074 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $21.4 per share | 664,983.60 |
| Feb 27, 2026 | Andrew W. Kush EVP & Chief Operating Officer | 32,948 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2026 | Jason J. Bundick EVP/Gen. Counsel/Corp. Secty. | 6,748 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2026 | Jason J. Bundick EVP/Gen. Counsel/Corp. Secty. | 35,364 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $21.4 per share | 756,789.60 |
| Feb 27, 2026 | Jason J. Bundick EVP/Gen. Counsel/Corp. Secty. | 39,455 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2026 | Jason J. Bundick EVP/Gen. Counsel/Corp. Secty. | 29,812 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $21.4 per share | 637,976.80 |
| Feb 27, 2026 | Jason J. Bundick EVP/Gen. Counsel/Corp. Secty. | 31,244 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2026 | Theodore Wahl President & CEO; Director | 509,101 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2026 | John Christopher Shea EVP & Chief Admin. Officer | 8,830 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2026 | John Christopher Shea EVP & Chief Admin. Officer | 39,099 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $21.4 per share | 836,718.60 |
| Feb 27, 2026 | John Christopher Shea EVP & Chief Admin. Officer | 44,452 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2026 | John Christopher Shea EVP & Chief Admin. Officer | 31,834 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $21.4 per share | 681,247.60 |
| Feb 27, 2026 | John Christopher Shea EVP & Chief Admin. Officer | 33,708 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2026 | Theodore Wahl President & CEO; Director | 44,476 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2026 | Theodore Wahl President & CEO; Director | 536,259 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $21.4 per share | 11,475,942.60 |
| Feb 27, 2026 | Theodore Wahl President & CEO; Director | 563,218 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |